US › Healthcare

Lunai Bioworks Inc. (LNAI)

US · Healthcare · Biotechnology

$2.55+6.69%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$20,942

Net profit

$-2.6M

Profit YoY

-1459.3%

EPS

$-0.10

Net margin

-12,278.6%

Key statistics

Market cap

$9.6M

Forward P/E

0.0

P/B

0.48

Book value

$-2.14

EPS (TTM)

$-57.95

52-week high

$21.60

52-week low

$1.00

50-day MA

$2.80

200-day MA

$5.14

Beta

0.35

Shareholding

Insiders

40.72%

Institutions

2.76%

Largest institutional holders

Fund	Stake
Vanguard Group Inc	1.37%
Geode Capital Management, LLC	0.50%
BlackRock Inc	0.35%
Nine Masts Capital Limited	0.28%
Citigroup Inc	0.28%
Vanguard Capital Management, LLC	0.27%
Virtu Financial LLC	0.21%
Vanguard Fiduciary Trust Co	0.19%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Lunai Bioworks Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.